Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets
Description
Report Scope
The report provides an overview of global cloud computing in cell biology, genomics and drug development, and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on branch of biology, deployment type, application, end user and region. Based on the branch of biology, the market is further segmented into human biology, microbiology, animal biology and plant biology. The market is categorized by deployment type into public cloud, private cloud and hybrid cloud. By application, the market is segmented as discovery and preclinical research, clinical trials, pharma manufacturing, plant and microbial gene analysis, and commercialization. The market is categorized based on end user into pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations (CROs), and others (such as academia, government or agritech). The study covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in each region.
The report also sheds light on developments related to venture capital (VC) and corporate investments, regulatory trends, and enterprise strategies of key firms as well as potential future opportunities stemming from cloud computing in cell biology, genomics, drug development of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis, and tariff assessments makes this report a critical resource for stakeholders, investors, and policymakers seeking to understand and capitalize on the rapidly developing field of cloud computing in cell biology, genomics and drug development. The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings of key companies in the cloud computing in cell biology, genomics and drug development market. It also has a dedicated section of company profiles that covers details of leading key market participants.
Report Includes
Companies Mentioned
Alphabet Inc. (Google Inc.)
Amazon Web Services Inc.
Arisglobal
Benchling
Box
Cisco Systems Inc.
Cognizant
Dnanexus Inc.
Ibm Corp.
Informatica Inc.
Microsoft
Oracle
Rescale Inc.
Salesforce Inc.
Sap Se
The report provides an overview of global cloud computing in cell biology, genomics and drug development, and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on branch of biology, deployment type, application, end user and region. Based on the branch of biology, the market is further segmented into human biology, microbiology, animal biology and plant biology. The market is categorized by deployment type into public cloud, private cloud and hybrid cloud. By application, the market is segmented as discovery and preclinical research, clinical trials, pharma manufacturing, plant and microbial gene analysis, and commercialization. The market is categorized based on end user into pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations (CROs), and others (such as academia, government or agritech). The study covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in each region.
The report also sheds light on developments related to venture capital (VC) and corporate investments, regulatory trends, and enterprise strategies of key firms as well as potential future opportunities stemming from cloud computing in cell biology, genomics, drug development of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis, and tariff assessments makes this report a critical resource for stakeholders, investors, and policymakers seeking to understand and capitalize on the rapidly developing field of cloud computing in cell biology, genomics and drug development. The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings of key companies in the cloud computing in cell biology, genomics and drug development market. It also has a dedicated section of company profiles that covers details of leading key market participants.
Report Includes
- 52 data tables and 51 additional tables
- An analysis of the global market for cloud computing applications in cell biology, genomics and drug development
- Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the market size and revenue growth prospects, along with a market share analysis by the branch of biology, deployment type, application, end user and region
- Facts and figures about market dynamics, opportunities and deterrents, technological advances, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Information about key partnerships between cloud service providers and pharma/biotech companies and investment in the pharmaceutical R&D sector
- A relevant patent analysis, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Profiles of the leading companies, including Alphabet Inc. (Google), Amazon Web Services (AWS) Inc., IBM Corp., Microsoft and Oracle Corp.
Companies Mentioned
Alphabet Inc. (Google Inc.)
Amazon Web Services Inc.
Arisglobal
Benchling
Box
Cisco Systems Inc.
Cognizant
Dnanexus Inc.
Ibm Corp.
Informatica Inc.
Microsoft
Oracle
Rescale Inc.
Salesforce Inc.
Sap Se
Table of Contents
135 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Technological Advances
- Market Dynamics and Growth Factors
- Segmental Analysis
- Regional Analysis
- Conclusion
- Chapter 2 Market Overview
- Overview and Market Definition
- Leveraging Cloud Computing for Collaboration
- Interactions Between Scalability and Collaboration
- Real-Time Applications of Cloud Computing to Achieve Scalability and Collaboration
- Porter's Five Forces Model
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Competition in the Industry
- Threat of Substitutes
- Macroeconomic Factors Analysis
- Growth of Biomedical R&D Budgets and Digital Transformation Budgets
- Rise of Precision Medicine and Data-Heavy Therapeutics
- Scaling Telehealth, Remote Studies and Decentralized Research Models
- Impact of the U.S. Tariffs
- Overview
- Direct Impact: Increased Operational Costs and R&D Expenditure
- Strategic and Operational Impacts
- Asymmetric Impact: Widening the Gap Between ""Haves"" and ""Have-Nots"
- Geopolitical and Long-Term Strategic Shifts
- Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Explosion of Biological Data - Driving Demand for Scalable Compute and Storage
- Rising Adoption of AI and Advanced Analytics in Biology Demands High-Performance Cloud Infrastructure
- Increasing Demand for Real-Time, Decentralized Collaboration in Pharmaceutical R&D
- Emergence of Cloud-Native Bioinformatics and Lab Informatics Vendors (SaaS Economics)
- Market Restraints
- Data Security and Privacy
- High Costs Associated with Cloud Implementation
- Market Opportunities
- Integration with Real-World Evidence and Clinical Data
- Commercialization of Cloud-Native Bioinformatics as a Service
- Chapter 4 Regulatory Landscape
- Overview
- The United States (U.S.)
- European Union (EU)
- Japan
- China
- India
- Chapter 5 Emerging Technologies and Developments
- Overview
- Cloud-Native Bioinformatics and Multiomics Integration
- Federated Cloud and Secure Data Sharing
- Digital Twins and Synthetic Data in Drug Development
- High-Performance Computing (HPC) in the Cloud for Genomics and Biology
- AI-Enabled Cloud Manufacturing and Real-World Evidence (RWE)
- Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis, by Branch of Biology
- Human Biology
- Microbiology
- Animal Biology
- Plant Biology
- Market Analysis, by Deployment Type
- Public Cloud
- Private Cloud
- Hybrid Cloud
- Market Analysis, by Application
- Discovery and Preclinical Research
- Clinical Trials
- Pharma Manufacturing
- Plant and Microbial Gene Analysis
- Commercialization
- Market Analysis, by End User
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- Contract Research Organizations (CROs)
- Others (Academia/Govt./Agritech, etc.)
- Geographic Breakdown
- Market Analysis, by Region
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 7 Patent Review/New Developments
- Key Takeaways
- Chapter 8 Competitive Landscape
- Overview
- Key Takeaways
- Cloud Computing Market for Cell Biology, Genomics and Drug Development - Major Companies
- Chapter 9 Appendix
- Methodology
- References
- Abbreviations
- Company Profiles
- ALPHABET INC. (GOOGLE INC.)
- AMAZON WEB SERVICES INC.
- ARISGLOBAL
- BENCHLING
- BOX
- CISCO SYSTEMS INC.
- COGNIZANT
- DNANEXUS INC.
- IBM CORP.
- INFORMATICA INC.
- MICROSOFT
- ORACLE
- RESCALE INC.
- SALESFORCE INC.
- SAP SE
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
